Prairie Capital Recapitalizes Kashi Clinical Laboratories
June 20, 2024
Prairie Capital partnered with founder Dr. Zahra Kashi and senior management to recapitalize Kashi Clinical Laboratories, a Portland, Oregon-based accredited clinical laboratory specializing in HLA typing, post-transplant monitoring, genomic sequencing and diagnostic testing. Prairie will support accelerated growth through investments in human capital, sales & marketing, technology and infrastructure, as well as pursuing add-on acquisitions.
- Buyers
- Prairie Capital
- Targets
- Kashi Clinical Laboratories
- Industry
- Healthcare Services
- Location
- Oregon, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.